Researchers from the Department of Biomedical Engineering at UNIST and the Center for Genomic Integrity at the Institute for Basic Science (IBS) have announced an advance in cancer gene therapy. Their innovative method enables precise destruction of cancer cell DNA by targeting only a single strand of the DNA double helix, significantly simplifying the process and reducing potential side effects.
This article was originally published on MedicalXpress.com